SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume following an executive interview where the CFO confirmed a purchase order with Marvell Technology and projected further scaling of orders, fueling a significant short squeeze. The community is actively discussing the company's transition from speculative R&D to production, with many investors highlighting the bullish implications of these commercial confirmations and the perceived breakdown of recent short-seller pressure.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing a historic short squeeze driven by extreme ownership concentration and limited float, prompting intense community debate over market manipulation and the potential for a sudden, sharp decline. While bullish investors point to the lack of available shares and ongoing short covering to justify further gains, many traders remain cautious of a looming reality check from significant corporate debt and the prospect of future equity dilution.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is seeing intense debate as investors weigh the potential of its Gallium Nitride (GaN) technology in the AI data center sector against significant concerns over its current valuation and lack of profitability. While bulls point to strategic partnerships and rising demand for power-efficient AI infrastructure, skeptics argue that the recent price surge is driven by speculative hype and an unsustainable price-to-sales ratio.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is trending as the market weighs a high-profile price target upgrade against a recent analyst downgrade, fueling intense debate over whether the company's dominant backlog and data center exposure justify its premium valuation. The community is actively tracking these conflicting signals, with many investors viewing the current price volatility as a potential buying opportunity for this long-term energy infrastructure play.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. The firm also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment includes products and services sold for applications within the data center, communication networks and commercial and industrial markets in North America and Latin America. The Asia Pacific segment consists of products and services sold for applications within the data center, communication networks and commercial and industrial markets throughout Greater China, Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Westerville, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is facing a mix of institutional profit-taking and technical resistance after a period of intense growth, yet the community remains deeply bullish on its long-term potential as a critical infrastructure provider for AI data centers. Investors are actively debating whether current valuation levels reflect the massive order backlog and AI tailwinds or if a short-term pullback is necessary to clear the path for future gains.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors weigh strong defense contract wins and production ramp-up narratives against significant volatility stemming from geopolitical instability and broader market sell-offs. While the community is actively debating the company's turnaround potential and free cash flow recovery, many are focused on whether current share price levels represent a bottom or if further downside is likely amid ongoing sector uncertainty.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently a focus for traders following a major $14.5 billion acquisition of Penumbra, which has sparked intense debate over dilution risks and long-term integration strategy. The community is actively weighing the firm's cardiovascular growth trajectory against recent stock volatility, with many retail investors treating the pullback as a potential buying opportunity while monitoring technical support levels.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending following positive clinical trial data for its CAR-T therapy, miv-cel, in Stiff Person Syndrome, which met all primary and secondary endpoints and supported plans for an upcoming BLA submission. The community is actively discussing the drug's potential as a first-in-class treatment and debating the impact of the company's subsequent equity offering, while some remain focused on the potential for a future acquisition given the promising trial results.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors focus on a critical Phase 3 trial nearing its 80-event milestone, fueling active community debate regarding a potential buyout versus institutional accumulation. While bears highlight the lack of recent press releases and ongoing legal arbitration, bulls are pointing to increased institutional stake-building and anticipated clinical data as primary catalysts for a significant valuation rerating.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant selling pressure and volatility as investors debate the impact of generative AI on its creative software dominance, while the company attempts to reassure the market through a new massive stock buyback program. Community sentiment is deeply polarized, with some traders viewing the current valuation as a generational entry point for a cash-flow-rich leader, while others fear a structural decline in the face of emerging AI competitors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Danish pharmaceutical company Novo Nordisk (NVO) on Tuesday said that it has submitted an application to the European Medicines Agency (EMA) for the approval of a new and higher dose of its blockbuster obesity treatment, Wegovy.NYSE-listed shares of the company were trading over 1% higher at the time of writing.The <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=916360">submission</a> to the EMA is based on data from two trials investigating the efficacy and safety of a higher dose of Semaglutide, the active ingredient in Wegovy, in people with obesity with or without type 2 diabetes. While one of the trials included 1,407 adults with obesity and not diabetes, the other included 512 adults with obesity and type 2 diabetes.The new 7.2 mg dose of Wegovy demonstrated a substantial average weight loss of 21% in people with obesity, with a third of participants losing 25% or more of their body weight compared with placebo, the company said.Data also indicated that Semaglutide 7.2 mg had a well-tolerated safety profile consistent with Semaglutide 2.4 mg, <a href="https://stocktwits.com/symbol/NVO">Novo Nordisk</a> added.Ludovic Helfgott, executive vice president and head of Product &amp; Portfolio Strategy at Novo Nordisk, said that the new dose was developed as a tailored option for people in need of additional support to achieve meaningful, sustained weight loss.In addition to the submission to the EMA, Novo Nordisk aims to make the higher dose of Wegovy widely available throughout the European Union.Wegovy is among Novo Nordisk’s blockbuster drugs. In the first quarter, Wegovy sales stood at DKK 17,360 million ($2.72 billion), marking a growth of 85% from the corresponding period of 2024, and accounting for over 22% of the company’s total sales in the period.On Stocktwits, retail sentiment around Novo Nordisk stayed unmoved within the ‘bearish’ territory over the past 24 hours while message volume stayed at ‘extremely low’ levels.<figure class="image"><img style="aspect-ratio:1364/128;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_08_at_11_24_34_AM_png_6c076523e1.webp" alt="NVO's Sentiment Meter and Message Volume as of 11:25 a.m. ET on July 8, 2025 | Source: Stocktwits" width="1364" height="128"><figcaption>NVO's Sentiment Meter and Message Volume as of 11:25 a.m. ET on July 8, 2025 | Source: Stocktwits</figcaption></figure>NVO stock is down by over 18% this year and by about 51% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/lvmh-stock-surges-as-luxury-goods-maker-appoints-longtime-arnault-confidante-to-lead-americas-turnaround/chFvvSpR5WK">LVMH Stock Surges As Luxury Goods Maker Appoints Longtime Arnault Confidante To Lead Americas Turnaround: Retail Remains Bearish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Novo Nordisk logo is displayed on a smartphone with stock market percentages in the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)

Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe

In addition to the submission to the EMA, Novo Nordisk aims to make the higher dose of Wegovy widely available throughout the European Union.

Current Price	$35.63
Prev Close	$35.89
Open	$35.93
Dividend Yield	N/A
50-Day Moving Average	$34.01
Beta	N/A
Avg. Volume	144.73
PE Ratio	N/A

52-Week High	$36.38
52-Week Low	$27.92
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

GGRW
Gabelli ETFs Trust - Gabelli Growth Innovators ETF

Feed

News

Sentiment

Fundamentals

Info

Latest GGRW News

GGRWGabelli ETFs Trust - Gabelli Growth Innovators ETF